MedTrace Logo

Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation

NCT00328237 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2006-06-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the incidence of neutrophil engraftment after transplantation of one or two cord blood units meeting a predetermined total minimum cell dose of 2.0 x 10 to the seventh total nucleated cell (TNC)/kg.

Conditions

Interventions

PROCEDURE

Cord Blood Transplant

Sponsors & Collaborators

  • Colorado Blood Cancer Institute

    lead OTHER

Principal Investigators

  • Peter McSweeney, MD · Colorado Blood Cancer Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00328237 on ClinicalTrials.gov